SAN ANTONIO, August 28, 2013 /PRNewswire/ --
Bio-Solutions Corp. (OTCQB: BISU) today announces a major step in their company's expansion process across the USA and commitment to growth across America; as management celebrates the national roll-out of a Direct Response Infomercial and Marketing Campaign for it's flagship product Type2Defense™.
Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.
Bill Gallagher, CEO of Bio-Solutions Corp said, "We are very excited to be launching our unique product via direct response television in the USA, and especially feeling confident that partnering with GVP Digital Media will give us the edge for a successful campaign."
Compared to other consumer groups, diabetics are 1.6 times more likely to use alternative medicine either exclusively or as a complement to traditional treatment. GVP Digital Media, a leader in Direct Response, will begin to actively market Type2Defense through their media contacts and network of brokers, sales consultants and agents. GVP has already started test marketing Type2Defense in a National radio campaign.
"We are extremely excited to be partnering with Type2Defense™," said Harry Oates, President of Direct Response Marketing for GVP Digital Media. "We believe that they offer a truly innovative and incredible product that today's consumers will soon be discovering through the direct response marketing endeavour we're engaging in." Bio-Solutions has already opened the retail marketplace on Amazon, and now television, radio and magazine advertising will support product sales and drive consumers to purchase the products, also through social media and their website.
Gallagher added "We will also be offering additional products as line extensions after the initial product launch. These may be at various flavors that will widen existing sales. " The demand for natural products that effectively control glucose continues to rise. Even in times of general economic distress, consumers increase their consumption of natural health products. Effective organic products likeType2 Defense can improve everyday wellbeing and save money on future medical costs by maintaining health.
About Bio-Solutions Corp.
Bio-Solutions Corp. markets new and very effective organic products; our lead product is Type2 Defense™. Type2Defense™ a Diabetic Supplement Drink. Type2Defense™ is a new dietary supplement that has been developed to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type 2 Diabetes. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants. Consumers can find more information about the company and its products by going to http://www.BioSolutionsCorp.com.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business
strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.
Bill Gallagher, President & CEO
Investor Relations Contact
SOURCE Bio-Solutions Corp